药物发现
Researchers have discovered that combining silybin and carvedilol is more effective against liver fibrosis than either drug alone. The pair targets key drivers of liver scarring, reducing collagen buildup in experimental models. Both drugs are already approved for other uses, paving the way for quick clinical testing.
由 AI 报道
总部位于美国的Insilico Medicine公司，由复星和腾讯支持，正在中国扩大研究基地，以开发一款AI驱动的药物发现工具Pharma.AI。该公司创始人Alex Zhavoronkov将这一工具比作“爱因斯坦”，旨在推动药物发现进入新领域。